A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: Diagnostic pitfalls of ancillary studies in sarcoma

Nicole D. Riddle, Ricardo J. Gonzalez, Julia A. Bridge, Scott Antonia, Marilyn M. Bui

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: The immunohistochemical hallmarks of gastrointestinal stromal tumors (GISTs) are positivity for CD117 (c-kit) and CD34; however, CD117 is not specifi c for GISTs, and the list of CD117+ tumors/tissues is increasing. Also, MDM2 is known to be amplifi ed in several types of mesenchymal tumors, including liposarcoma. Methods: We report a spindle cell sarcoma arising in the mediastinum that morphologically and immunohistochemically mimicked GIST to illustrate the potential diagnostic pitfalls of ancillary studies in sarcoma and their appropriate use in conjunction with clinical content. Clinical information was obtained from electronic medical databases. Cytological, histological, and ancillary studies were retrieved from the archives of the Department of Anatomic Pathology at Moffi tt Cancer Center. Literature of the last 20 years was reviewed. The role of biomarkers and their molecular testing in the prognosis and prediction of GIST is also discussed. Results: A 75-year-old woman with a history of well-differentiated liposarcoma of the trunk/inguinal canal 5 years earlier developed a 5.5-cm heterogeneously enhancing mediastinal mass by computed tomography. Fine needle aspiration biopsy revealed spindle cells with moderate pleomorphism and immunohistochemically reactive to CD117 and CD34 suggestive of GIST, but the clinical picture was unusual for GIST. Mutational analyses for KIT and platelet-derived growth factor receptor alpha (PDGFRα) were negative; DOG1 was not immunoactive, and this was believed to rule out GIST. An additional study of MDM2 by fl uorescent in situ hybridization was positive, suggesting that this tumor was a dedifferentiated liposarcoma vs a spindle cell sarcoma not otherwise specifi ed. Conclusions: CD117+/CD34+ sarcoma is not diagnostic for GIST. KIT and PDGFRα mutational analyses are important in confi rming a diagnosis of GIST and predicting its response to imatinib therapy. MDM2+ sarcoma is not diagnostic for liposarcoma. Although MDM2 is almost always positive in well-differentiated liposarcoma, which is useful in differentiating benign from atypical/well-differentiated lipomatous tumor, it should not be used in differentiating liposarcoma from other sarcomas.

Original languageEnglish (US)
Pages (from-to)152-159
Number of pages8
JournalCancer Control
Volume18
Issue number3
DOIs
StatePublished - Jul 2011

Fingerprint

Gastrointestinal Stromal Tumors
Sarcoma
Liposarcoma
Platelet-Derived Growth Factor alpha Receptor
Neoplasms
Medical Electronics
Inguinal Canal
Mediastinum
Fine Needle Biopsy
In Situ Hybridization
Biomarkers
Tomography
Databases
Pathology

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor : Diagnostic pitfalls of ancillary studies in sarcoma. / Riddle, Nicole D.; Gonzalez, Ricardo J.; Bridge, Julia A.; Antonia, Scott; Bui, Marilyn M.

In: Cancer Control, Vol. 18, No. 3, 07.2011, p. 152-159.

Research output: Contribution to journalArticle

Riddle, Nicole D. ; Gonzalez, Ricardo J. ; Bridge, Julia A. ; Antonia, Scott ; Bui, Marilyn M. / A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor : Diagnostic pitfalls of ancillary studies in sarcoma. In: Cancer Control. 2011 ; Vol. 18, No. 3. pp. 152-159.
@article{7e4e02d1f76d4489b62cf3ca030970b4,
title = "A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: Diagnostic pitfalls of ancillary studies in sarcoma",
abstract = "Background: The immunohistochemical hallmarks of gastrointestinal stromal tumors (GISTs) are positivity for CD117 (c-kit) and CD34; however, CD117 is not specifi c for GISTs, and the list of CD117+ tumors/tissues is increasing. Also, MDM2 is known to be amplifi ed in several types of mesenchymal tumors, including liposarcoma. Methods: We report a spindle cell sarcoma arising in the mediastinum that morphologically and immunohistochemically mimicked GIST to illustrate the potential diagnostic pitfalls of ancillary studies in sarcoma and their appropriate use in conjunction with clinical content. Clinical information was obtained from electronic medical databases. Cytological, histological, and ancillary studies were retrieved from the archives of the Department of Anatomic Pathology at Moffi tt Cancer Center. Literature of the last 20 years was reviewed. The role of biomarkers and their molecular testing in the prognosis and prediction of GIST is also discussed. Results: A 75-year-old woman with a history of well-differentiated liposarcoma of the trunk/inguinal canal 5 years earlier developed a 5.5-cm heterogeneously enhancing mediastinal mass by computed tomography. Fine needle aspiration biopsy revealed spindle cells with moderate pleomorphism and immunohistochemically reactive to CD117 and CD34 suggestive of GIST, but the clinical picture was unusual for GIST. Mutational analyses for KIT and platelet-derived growth factor receptor alpha (PDGFRα) were negative; DOG1 was not immunoactive, and this was believed to rule out GIST. An additional study of MDM2 by fl uorescent in situ hybridization was positive, suggesting that this tumor was a dedifferentiated liposarcoma vs a spindle cell sarcoma not otherwise specifi ed. Conclusions: CD117+/CD34+ sarcoma is not diagnostic for GIST. KIT and PDGFRα mutational analyses are important in confi rming a diagnosis of GIST and predicting its response to imatinib therapy. MDM2+ sarcoma is not diagnostic for liposarcoma. Although MDM2 is almost always positive in well-differentiated liposarcoma, which is useful in differentiating benign from atypical/well-differentiated lipomatous tumor, it should not be used in differentiating liposarcoma from other sarcomas.",
author = "Riddle, {Nicole D.} and Gonzalez, {Ricardo J.} and Bridge, {Julia A.} and Scott Antonia and Bui, {Marilyn M.}",
year = "2011",
month = "7",
doi = "10.1177/107327481101800302",
language = "English (US)",
volume = "18",
pages = "152--159",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "3",

}

TY - JOUR

T1 - A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor

T2 - Diagnostic pitfalls of ancillary studies in sarcoma

AU - Riddle, Nicole D.

AU - Gonzalez, Ricardo J.

AU - Bridge, Julia A.

AU - Antonia, Scott

AU - Bui, Marilyn M.

PY - 2011/7

Y1 - 2011/7

N2 - Background: The immunohistochemical hallmarks of gastrointestinal stromal tumors (GISTs) are positivity for CD117 (c-kit) and CD34; however, CD117 is not specifi c for GISTs, and the list of CD117+ tumors/tissues is increasing. Also, MDM2 is known to be amplifi ed in several types of mesenchymal tumors, including liposarcoma. Methods: We report a spindle cell sarcoma arising in the mediastinum that morphologically and immunohistochemically mimicked GIST to illustrate the potential diagnostic pitfalls of ancillary studies in sarcoma and their appropriate use in conjunction with clinical content. Clinical information was obtained from electronic medical databases. Cytological, histological, and ancillary studies were retrieved from the archives of the Department of Anatomic Pathology at Moffi tt Cancer Center. Literature of the last 20 years was reviewed. The role of biomarkers and their molecular testing in the prognosis and prediction of GIST is also discussed. Results: A 75-year-old woman with a history of well-differentiated liposarcoma of the trunk/inguinal canal 5 years earlier developed a 5.5-cm heterogeneously enhancing mediastinal mass by computed tomography. Fine needle aspiration biopsy revealed spindle cells with moderate pleomorphism and immunohistochemically reactive to CD117 and CD34 suggestive of GIST, but the clinical picture was unusual for GIST. Mutational analyses for KIT and platelet-derived growth factor receptor alpha (PDGFRα) were negative; DOG1 was not immunoactive, and this was believed to rule out GIST. An additional study of MDM2 by fl uorescent in situ hybridization was positive, suggesting that this tumor was a dedifferentiated liposarcoma vs a spindle cell sarcoma not otherwise specifi ed. Conclusions: CD117+/CD34+ sarcoma is not diagnostic for GIST. KIT and PDGFRα mutational analyses are important in confi rming a diagnosis of GIST and predicting its response to imatinib therapy. MDM2+ sarcoma is not diagnostic for liposarcoma. Although MDM2 is almost always positive in well-differentiated liposarcoma, which is useful in differentiating benign from atypical/well-differentiated lipomatous tumor, it should not be used in differentiating liposarcoma from other sarcomas.

AB - Background: The immunohistochemical hallmarks of gastrointestinal stromal tumors (GISTs) are positivity for CD117 (c-kit) and CD34; however, CD117 is not specifi c for GISTs, and the list of CD117+ tumors/tissues is increasing. Also, MDM2 is known to be amplifi ed in several types of mesenchymal tumors, including liposarcoma. Methods: We report a spindle cell sarcoma arising in the mediastinum that morphologically and immunohistochemically mimicked GIST to illustrate the potential diagnostic pitfalls of ancillary studies in sarcoma and their appropriate use in conjunction with clinical content. Clinical information was obtained from electronic medical databases. Cytological, histological, and ancillary studies were retrieved from the archives of the Department of Anatomic Pathology at Moffi tt Cancer Center. Literature of the last 20 years was reviewed. The role of biomarkers and their molecular testing in the prognosis and prediction of GIST is also discussed. Results: A 75-year-old woman with a history of well-differentiated liposarcoma of the trunk/inguinal canal 5 years earlier developed a 5.5-cm heterogeneously enhancing mediastinal mass by computed tomography. Fine needle aspiration biopsy revealed spindle cells with moderate pleomorphism and immunohistochemically reactive to CD117 and CD34 suggestive of GIST, but the clinical picture was unusual for GIST. Mutational analyses for KIT and platelet-derived growth factor receptor alpha (PDGFRα) were negative; DOG1 was not immunoactive, and this was believed to rule out GIST. An additional study of MDM2 by fl uorescent in situ hybridization was positive, suggesting that this tumor was a dedifferentiated liposarcoma vs a spindle cell sarcoma not otherwise specifi ed. Conclusions: CD117+/CD34+ sarcoma is not diagnostic for GIST. KIT and PDGFRα mutational analyses are important in confi rming a diagnosis of GIST and predicting its response to imatinib therapy. MDM2+ sarcoma is not diagnostic for liposarcoma. Although MDM2 is almost always positive in well-differentiated liposarcoma, which is useful in differentiating benign from atypical/well-differentiated lipomatous tumor, it should not be used in differentiating liposarcoma from other sarcomas.

UR - http://www.scopus.com/inward/record.url?scp=79959353497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959353497&partnerID=8YFLogxK

U2 - 10.1177/107327481101800302

DO - 10.1177/107327481101800302

M3 - Article

C2 - 21666577

AN - SCOPUS:79959353497

VL - 18

SP - 152

EP - 159

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 3

ER -